Literature DB >> 6401992

Risk factors for peripheral atherosclerosis. Retrospective evaluation by stepwise discriminant analysis.

E Pilger, H Pristautz, K P Pfeiffer, G Kostner.   

Abstract

To evaluate the optimal discriminators for peripheral atherosclerosis, we studied retrospectively 49 male patients and 39 male controls between 40 and 60 years of age. In addition to hypertension, cigarette smoking, diabetes mellitus, and hyperuricemia, we determined the most common lipids, lipoproteins, and apolipoproteins. Highly significant differences of median values between patients and controls in decreasing order of magnitude were recorded for apo A-II/apo B, apo A-I/apo B, apo B, total cholesterol, and LDL-cholesterol. A retrospective classification of patients and controls under optimal conditions with one variable (apo A-I/apo B) yielded an error rate of 25%. We found that apolipoproteins were better discriminators for peripheral atherosclerosis than than were lipids or lipoprotein lipids. The application of a linear regression discriminant analysis including 29 variables greatly decreased the rate of error and increased the sensitivity and specificity of the classification. From 229 possible models, we used an economic selection strategy to sort out those which either gave the best segregation or were considered the most practicable. The optimal model with 14 variables gave an error rate of less than 5% for the group studied. Suboptimal models yielded error rates between 13% and 18%. We conclude that a mathematical treatment of laboratory data which includes lipid parameters in addition to apolipoprotein values can improve the classification of peripheral vascular atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401992     DOI: 10.1161/01.atv.3.1.57

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  8 in total

1.  The risk concept in medicine--statistical and epidemiological aspects: a case report for applied mathematics in cardiology.

Authors:  K P Pfeiffer; T Kenner
Journal:  Theor Med       Date:  1986-10

2.  Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.

Authors:  C S Shelley; F E Baralle
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

3.  Coronary myointimal hyperplasia in freshwater Lake Michigan salmon (genus Oncorhynchus). Evidence for lipoprotein-related atherosclerosis.

Authors:  R P Eaton; T McConnell; J G Hnath; W Black; R E Swartz
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

4.  Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.

Authors:  Lawrence W Castellani; Cara N Nguyen; Sarada Charugundla; Michael M Weinstein; Chau X Doan; William S Blaner; Nuttaporn Wongsiriroj; Aldons J Lusis
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

5.  Serum lipids and lipoproteins in patients with primary gout.

Authors:  A Ulreich; G M Kostner; K P Pfeiffer; P Sedlmayr; F Rainer
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer.

Authors:  M A Lucero; D Sanchez; A R Ochoa; F Brunel; G N Cohen; F E Baralle; M M Zakin
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

7.  The human apolipoprotein AII gene: structural organization and sites of expression.

Authors:  T J Knott; S C Wallis; M E Robertson; L M Priestley; M Urdea; L B Rall; J Scott
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

8.  The interaction of human plasma low density lipoproteins with glycosamino-glycans: influence of the chemical composition.

Authors:  G M Kostner; R Zechner; M Bihari-Varga; E Gruber
Journal:  Lipids       Date:  1985-01       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.